← Eichor
Condition: Toxic Epidermal Necrolysis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Toxic Epidermal Necrolysis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic E
EARLY_Phase 1 · 1 location(s) · Peng Zhang · NCT06119490LYell SYndrome MEsenchymal Stromal Cells Treatment
Phase 1/Phase 2 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04711200Drug Reactions Sampling (COLLECTIONTOXIDERMIES)
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT03659227
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.